The British Medical Community Approach to Drug Labelling, Diethylstilbestrol use, Public Awareness

Extract from: Meyler’s Side Effects of Endocrine and Metabolic Drugs

Meyler's Side Effects of Endocrine and Metabolic Drugs book cover image
The DES drug was prescribed until 1973 in the UK

In Britain the medical community was alerted to the risks by an editorial in the British Medical Journal in 1971, but it was only in 1973 that the Committee on Safety of Medicines advised against the use of Diethylstilbestrol during pregnancy. In Britain, drugs were commonly not labelled with information about their contents, nor with warning of risk until well into the 1990s, thus patients were kept in ignorance.
No measures have yet been taken in Britain to alert the public to the need for medical surveillance of women who have been exposed to Diethylstilbestrol in utero. It is estimated that in the U.S.A, the Netherlands, and France, diethylstilbestrol was given to over 5.3 million pregnant women, and it is known that it has been given to pregnant women in most parts of the world
. ”

Extract from: Meyler’s Side Effects of Endocrine and Metabolic Drugs
by Jeffrey K. Aronson.

More DES DiEthylStilbestrol Resources

Author: DES Daughter

Activist, blogger and social media addict committed to shedding light on a global health scandal and dedicated to raise DES awareness.

Have your say! Share your views

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.